Heart Attack
Boston Scientific SYNERGY Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element Platinum Chromium Stent
Published in Clinical Trials Week, November 28th, 2011
2011 NOV 28 -- Boston Scientific Corporation (NYSE: BSX) reports results from the EVOLVE First Human Use trial demonstrating the non-inferiority of the SYNERGY™ Everolimus-Eluting Stent System compared to the PROMUS Element™ Everolimus-Eluting Stent System in treating de novo coronary artery lesions. The trial provided 30-day clinical and six-month angiographic primary endpoint data evaluating the safety and effectiveness of the bioabsorbable polymer-coated SYNERGY Stent. Results were presented today during a late-breaking clinical session by Professor Ian T. Meredith, M.B.B.S., Ph.D., Director of MonashHeart, Monash Medical Centre, Melbourne, Australia, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2011-11-28)
More Articles from Clinical Trials Week
- Globins
Akebia Therapeutics Announces Presentation of Clinical Data at Kidney Week 2011 - Clinical Trial Research
Bio-Path Holdings Reports Third Quarter 2011 Financial Results - Cancer Vaccines
Bioniche Life Sciences Inc. Congratulates Dr. Alvaro Morales on his Appointment as Member of the Order of Canada - Clinical Trial Research
Biotech Leader Provides Testimony on Bioethical Issues in International Clinical Trials - Clinical Trial Research
Cerulean Pharma Presents Final Data from Phase 1/2a Clinical Study of CRLX101 at AACR-NCI-EORTC - Clinical Trial Research
Data from Royal London Hospital Advance Knowledge in Clinical Trial Research - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
